Osaic Holdings’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.25M Sell
37,482
-5,190
-12% -$454K ﹤0.01% 1677
2025
Q4
$3.62M Buy
42,672
+33,110
+346% +$2.64M 0.01% 1624
2025
Q3
$681K Sell
9,562
-332
-3% -$22.9K ﹤0.01% 3157
2025
Q2
$650K Buy
9,894
+1,629
+20% +$106K ﹤0.01% 2887
2025
Q1
$584K Sell
8,265
-14,538
-64% -$1.01M ﹤0.01% 2726
2024
Q4
$661K Buy
22,803
+16,371
+255% +$1.13M ﹤0.01% 2542
2024
Q3
$454K Sell
6,432
-10,150
-61% -$707K ﹤0.01% 2963
2024
Q2
$1.1M Buy
16,582
+194
+1% +$12.7K ﹤0.01% 2127
2024
Q1
$1.11M Buy
16,388
+1,817
+12% +$120K ﹤0.01% 2234
2023
Q4
$901K Sell
14,571
-23,595
-62% -$1.39M ﹤0.01% 2623
2023
Q3
$2.25M Buy
38,166
+5,235
+16% +$321K ﹤0.01% 1890
2023
Q2
$1.97M Buy
32,931
+231
+0.7% +$13.7K ﹤0.01% 1886
2023
Q1
$1.91M Buy
32,700
+17,745
+119% +$1.07M ﹤0.01% 1858
2022
Q4
$929K Sell
14,955
-1,113
-7% -$66.9K ﹤0.01% 2438
2022
Q3
$908K Sell
16,068
-2,640
-14% -$163K ﹤0.01% 2330
2022
Q2
$1.2M Sell
18,708
-8,616
-32% -$547K ﹤0.01% 2107
2022
Q1
$16M Buy
27,324
+9,240
+51% +$586K 0.03% 532
2021
Q4
$1.2M Sell
18,084
-26,448
-59% -$1.68M ﹤0.01% 2230
2021
Q3
$2.72M Buy
44,532
+26,985
+154% +$1.72M 0.01% 1468
2021
Q2
$1.09M Sell
17,547
-231
-1% -$14K ﹤0.01% 2282
2021
Q1
$1.05M Sell
17,778
-2,082
-10% -$126K ﹤0.01% 2184
2020
Q4
$1.19M Sell
19,860
-570
-3% -$32.5K ﹤0.01% 1886
2020
Q3
$1.11M Sell
20,430
-4,785
-19% -$258K ﹤0.01% 1745
2020
Q2
$1.29M Buy
25,215
+6,186
+33% +$311K ﹤0.01% 1555
2020
Q1
$856K Buy
+19,029
New +$960K ﹤0.01% 1656

Other funds holding IHE